Bio-thera Solutions, Ltd. Class ASSE: 688177

Announcement on the Status of the EU GMP Inspection at the Yonghe Facility

Jun 15, 2026 · Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange

Announcement on the Status of the EU GMP Inspection at the Yonghe Facility

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Bio-thera Solutions, Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Marketing Authorization Approval of BAT2206 (Ustekinumab Injection) by Singapore HSAJun 11
Announcement on Obtaining Drug Registration Certificate for ICHALIG®/XICHALIG® (Ustekinumab Injection)May 22
Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi(R) and Simponi Aria(R)May 19

All Bio-thera Solutions, Ltd. Class A news releases